Herbert Raymond Henney
Keine laufenden Positionen mehr
Profil
Herbert Raymond Henney worked as a Senior Director-Medical Affairs at Savient Pharmaceuticals, Inc. and as a Vice President-Clinical & Regulatory Affairs at W World Corp.
He also worked at Acorda Therapeutics, Inc. as a Vice President-Clinical Development from 2011 to 2014.
Henney holds a doctorate degree from the Medical University of South Carolina and an undergraduate degree from Temple University (Pennsylvania).
Ehemalige bekannte Positionen von Herbert Raymond Henney
| Unternehmen | Position | Ende |
|---|---|---|
| ACORDA THERAPEUTICS, INC. | Technik-/Wissenschafts-/F&E-Leiter | 01.04.2014 |
| SAVIENT PHARMACEUTICALS INC | Technik-/Wissenschafts-/F&E-Leiter | - |
| W WORL | Technik-/Wissenschafts-/F&E-Leiter | - |
Ausbildung von Herbert Raymond Henney
| Temple University (Pennsylvania) | Undergraduate Degree |
| Medical University of South Carolina | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| ACORDA THERAPEUTICS, INC. | Health Technology |
| W WORL | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Savient Pharmaceuticals, Inc.
 Savient Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Savient Pharmaceuticals, Inc. operates as a specialty biopharmaceutical company, which develops, manufactures and markets pharmaceutical products. The company focuses on developing and commercializing KRYSTEXXA for the treatment of chronic gout in adult patients who do not respond to conventional therapy. It also sells and distributes branded and generic versions of oxandrolone, a drug used to promote weight gain following involuntary weight loss. The company was founded in 1980 is headquartered in East Brunswick, NJ. | Health Technology |
